ZA

Zurimed Technologies Ag

www.zurimed.com link_icon

Company Research Report: ZuriMED Technologies AG



Company Overview



Name and Mission


  • Company Name: ZuriMED Technologies AG

  • Mission: ZuriMED aims to revolutionize soft tissue repair in orthopedic sports medicine by developing breakthrough technologies and products to improve surgeons' quality of treatment and patients' quality of life.


Founding and Key People


  • Founded: 2015

  • Founders and Key People:

  • Xiang Li: CEO & Co-Founder

  • Elias Bachmann: CTO & Co-Founder

  • Other key personnel include Pol Banzet (Head of Development), Sascha Brun (Head of Active Devices Development), Andrea Möhl (Head of Clinical Affairs), and others.


Headquarters


  • Location: Lengghalde 5, 8008 Zurich, Switzerland


Number of Employees


  • Total Employees: No information is available.


Revenue


  • Revenue: No information is available.


Company Recognition


  • Known For: ZuriMED is renowned for its FiberLocker® System, which is a game changer in shoulder surgery, as well as its contribution to orthopedic biomechanics.


Products



Overview of Products


  • ZuriMED develops products focusing on soft tissue repair, especially in orthopedic sports medicine.


Detailed Product List



FiberLocker® System


  • Description: A breakthrough technology for the arthroscopic augmentation of the rotator cuff repair.

  • Key Features:

  • Comprises a synthetic PET implant (SpeedPatch® PET) and a single-use surgical instrument (FiberLocker® Instrument SN).

  • Powered by a commercially available shaver unit.

  • Patented sewing-like technology for strong interwoven fiber-and-tendon networks.

  • Easy and fast application, allowing knotless fixation in 90 seconds.

  • Supported by pre-clinical and biomechanical studies showing improved mechanical properties.

  • Not available for sale in the United States.


BTB-Converter™


  • Description: Used for knee ligament reconstruction.

  • Key Features: Developed over eight years through collaboration with ETH Zürich and Swiss surgeons. The technology has been out-licensed.


VariLoop™


  • Description: Enables superior ligament fixation.

  • Key Features: Self-flipping, knotless design with high reliability and strength, developed and out-licensed by ZuriMED.


Recent Developments



Recent Achievements


  • 2024: Won ATiO Early-Stage Pitch Contest.

  • 2023: Closed Series-A financing round, raising 14.5 million CHF.

  • 2022: Awarded the Innosuisse Project Grant and the Innosuisse Scale-Up Award to support expansion.

  • 2019: Obtained the Innosuisse Certificate.


New Products and Features


  • Product Launches: Focus remains on the FiberLocker® System.

  • New Features: Continuous enhancement of existing technologies with a focus on expanding indications for use and improving implant integration.


Partnerships and Collaborations


  • Collaboration with University Hospital Balgrist and other research partners to co-develop breakthrough technologies for soft tissue repair.


Conclusion



ZuriMED Technologies AG is a forward-thinking company revolutionizing the field of orthopedic sports medicine through innovative soft tissue repair solutions. With its strategic collaborations, innovative product offerings like the FiberLocker® System, and recent financial accomplishments, ZuriMED is poised for continued growth and expansion in the medical device industry.